Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Efficacy by Baseline Disease Characteristics and Demographics in Two Pivotal Phase 3 Trials

Leon Kircik, Linda Stein Gold, James Del Rosso, Seemal R. Desai, Brad P. Glick, Howard Sofen, Anna M. Tallman, David S. Rubenstein, Janine Fournier, Philip M. Brown

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)s7
JournalSKIN: Journal of Cutaneous Medicine
Issue number2
StatePublished - 4 Mar 2022

Cite this